Legend Biotech Corporation – NASDAQ:LEGN
Legend Biotech stock price today
$36.5
+4.00
+12.34%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in about 15 hours
Legend Biotech stock price monthly change
-40.24%
month
Legend Biotech stock price quarterly change
-40.24%
quarter
Legend Biotech stock price yearly change
-44.65%
year
Legend Biotech key metrics
Market Cap | 6.04B |
Enterprise value | 7.64B |
P/E | -16.58 |
EV/Sales | 70.36 |
EV/EBITDA | -17.38 |
Price/Sales | 72.06 |
Price/Book | 13.91 |
PEG ratio | 2.35 |
EPS | -2.61 |
Revenue | 342.79M |
EBITDA | -378.32M |
Income | -465.94M |
Revenue Q/Q | 158.67% |
Revenue Y/Y | 231.84% |
Profit margin | -411.69% |
Oper. margin | -365.38% |
Gross margin | -4.57% |
EBIT margin | -365.38% |
EBITDA margin | -110.36% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeLegend Biotech stock price history
Legend Biotech stock forecast
Legend Biotech financial statements
| Jun 2023 | 73.33M | -199.12M | -271.55% |
|---|---|---|---|
| Sep 2023 | 96.01M | -62.20M | -64.79% |
| Dec 2023 | 79.46M | -144.81M | -182.24% |
| Mar 2024 | 93.99M | -59.79M | -63.62% |
| Sep 2025 | 253.44M | -19.65M | -7.76% |
|---|---|---|---|
| Dec 2025 | 291.46M | -6.18M | -2.12% |
| Mar 2026 | 258.25M | 68.53M | 26.54% |
| Mar 2026 | 198.37M | 33.88M | 17.08% |
Analysts Price target
Financials & Ratios estimates
| Jun 2023 | 1930659000 | 523.62M | 27.12% |
|---|---|---|---|
| Sep 2023 | 1839334000 | 499.69M | 27.17% |
| Dec 2023 | 1848609000 | 589.93M | 31.91% |
| Mar 2024 | 1775107000 | 604.38M | 34.05% |
| Jun 2023 | -95.73M | -123.58M | 789.89M |
|---|---|---|---|
| Sep 2023 | -60.84M | -209.07M | 961K |
| Dec 2023 | -93.23M | 405.10M | 925K |
| Mar 2024 | 16.18M | -396.81M | 831K |
Legend Biotech alternative data
| Sep 2023 | 1,576 |
|---|---|
| Oct 2023 | 1,576 |
| Nov 2023 | 1,576 |
| Dec 2023 | 1,700 |
| Jan 2024 | 1,700 |
| Feb 2024 | 1,700 |
| Mar 2024 | 1,800 |
| Apr 2024 | 1,800 |
| May 2024 | 1,800 |
| Jun 2024 | 2,000 |
| Jul 2024 | 2,000 |
Legend Biotech other data
21.61%
+2.90%
of LEGN is owned by hedge funds
147
-1
60.87M
+8.17M
shares is hold by hedge funds
| Quarter | Transcript |
|---|---|
| Q1 2024 13 May 2024 | Q1 2024 Earnings Call Transcript |
| Q4 2023 11 Mar 2024 | Q4 2023 Earnings Call Transcript |
| Q3 2023 20 Nov 2023 | Q3 2023 Earnings Call Transcript |
| Q2 2023 15 Aug 2023 | Q2 2023 Earnings Call Transcript |
Why Johnson & Johnson's Strong Buy Rating Is Justified (Rating Upgrade)
Top 5 Commercial Biotech Buyout Candidates: Legend Biotech (No. 4)
2seventy bio's Abecma: Compelling Investment In Multiple Myeloma Despite Competition
Bristol-Myers Squibb's Winning Formula: Dividends, M&A, And Innovation
Week In Review: Legend Partners DLL3 CAR-T Candidate With Novartis In $1.2 Billion Deal
Arcellx: A Strong Contender In The CAR-T Multiple Myeloma Market
Legend Biotech: Working On Supply Issues
Future Prospects For Johnson & Johnson Following Strong Q2 Performance
Allogene: I Am Less Sanguine About Allogeneic CAR-T's Prospects Than Before
-
What's the price of Legend Biotech stock today?
One share of Legend Biotech stock can currently be purchased for approximately $36.5.
-
When is Legend Biotech's next earnings date?
Unfortunately, Legend Biotech's (LEGN) next earnings date is currently unknown.
-
Does Legend Biotech pay dividends?
No, Legend Biotech does not pay dividends.
-
How much money does Legend Biotech make?
Legend Biotech has a market capitalization of 6.04B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 143.7% to 285.14M US dollars.
-
What is Legend Biotech's stock symbol?
Legend Biotech Corporation is traded on the NASDAQ under the ticker symbol "LEGN".
-
What is Legend Biotech's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Legend Biotech?
Shares of Legend Biotech can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Legend Biotech have?
As Jul 2024, Legend Biotech employs 2,000 workers, which is 11% more then previous quarter.
-
When Legend Biotech went public?
Legend Biotech Corporation is publicly traded company for more then 5 years since IPO on 5 Jun 2020.
-
What is Legend Biotech's official website?
The official website for Legend Biotech is legendbiotech.com.
-
Where are Legend Biotech's headquarters?
Legend Biotech is headquartered at 2101 Cottontail Lane, Somerset, NJ.
-
How can i contact Legend Biotech?
Legend Biotech's mailing address is 2101 Cottontail Lane, Somerset, NJ and company can be reached via phone at +7 323175050.
Legend Biotech company profile:
Legend Biotech Corporation
legendbiotech.comExchange:
NASDAQ
Full time employees:
2,400
Industry:
Biotechnology
Sector:
Healthcare
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multiple myeloma (MM), as well as a comparison of the treatment with standard triplet therapy in revlimid-refractory multiple myeloma. The company also has a portfolio of earlier-stage autologous product candidates, which are in Phase I clinical trials for the treatment of gastric cancer and T cell lymphoma. In addition, it is developing CAR-T product candidates targeting CD20/CD22/CD19 for the treatment of non-hodgkins lymphoma, diffuse large B-cell lymphoma, and acute lymphoblastic leukemia. Further, the company has product candidates in early preclinical and clinical development for the treatment of solid tumors as well as infectious diseases. It has collaboration and license agreement with Janssen Biotech, Inc. for the development and commercialization of ciltacabtagene autoleucel. Legend Biotech Corporation was founded in 2014 and is based in Somerset, New Jersey. Legend Biotech Corporation is a subsidiary of Genscript Biotech Corporation.
2101 Cottontail Lane
Somerset, NJ 08873
Somerset, NJ 08873
CIK: 0001801198
ISIN: US52490G1022
CUSIP: 52490G102
